Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2008
Business Overview: Medifast operates in the weight management industry through two primary segments: the "Medifast" segment (Direct, Take Shape for Life, and Doctors channels) and the "All Other" segment (Hi-Energy and Medifast Weight Control Centers). The company reported strong growth driven by its Take Shape for Life division and expansion of brick-and-mortar clinics.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2008 |
Six Months Ended June 30, 2007 |
Three Months Ended June 30, 2008 |
Three Months Ended June 30, 2007 |
|---|---|---|---|---|
| Revenue | $52,706,000 | $42,130,000 | $27,537,000 | $22,041,000 |
| Gross Profit | $39,929,000 | $31,709,000 | $20,860,000 | $16,678,000 |
| Gross Margin | 75.8% | 75.3% | 75.8% | 75.7% |
| Net Income | $2,937,000 | $2,282,000 | $1,572,000 | $909,000 |
| Diluted EPS | $0.21 | $0.17 | $0.11 | $0.07 |
| Cash & Equivalents | $2,046,000 (as of June 30, 2008) | |||
| Total Debt | $7,144,000 (Line of Credit + Long-term) | |||
| Working Capital | $10,861,000 (Current Assets - Current Liabilities) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 25% year-over-year for the six-month period ($10.6M increase). The Take Shape for Life division grew 72%, and Medifast Weight Control Centers grew 62%. Conversely, the "Doctors" channel declined 23%.
- Profitability: Net income rose 29% for the six-month period and 73% for the quarter. Gross margins improved slightly due to manufacturing efficiencies and new shipping rules.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased by $7.1M for the six months. This was driven by a $4.5M increase in variable commissions for Take Shape for Life and higher salaries/benefits due to hiring for clinic expansion and bringing the call center in-house.
- Cash Flow: Net cash provided by operating activities was $3.35M, a decrease from $3.93M in the prior year, largely due to a $1.86M increase in inventory levels and a $987k increase in prepaid taxes. Investing activities used $4.55M, primarily for property and equipment purchases.
- Debt: The line of credit increased by $1.1M to $2.7M to support operations and expansion.
Outlook, Risks, and Management Commentary
- Expansion Strategy: Management highlighted the success of the "Take Shape for Life" health coach model, with active coaches growing 87% to 2,800. The company plans to open additional corporately owned clinics in Houston and Dallas by year-end and has sold franchise rights in Baltimore and California.
- Cost Pressures: The company noted a negative impact from increasing raw material costs due to inflation, though the impact on financial position was described as minimal in the prior year.
- Tax Outlook: The effective tax rate for the first six months was 32.6%. Management anticipates a tax rate of approximately 32-34% for the full year 2008.
- Seasonality: Historically, November/December is a slow period, while January/February sees a surge. Management noted that seasonality is decreasing as consumers view the products as year-round health solutions.
- Legal Contingency: The company is involved in litigation with Leonard Z. Sotomeyer regarding consulting agreements. Medifast denies wrongdoing and believes the outcome will not materially impact operations.
Investor Verification Checklist
- Inventory Build-up: Verify the necessity of the $1.86M increase in inventory against sales velocity to ensure no obsolescence risk.
- Take Shape for Life Sustainability: Assess the retention rates of the 2,800 active health coaches and the variable cost structure (commissions) supporting this growth.
- Clinic Economics: Review the profitability timeline for the new clinics in Houston and Dallas, as start-up costs currently depress the "All Other" segment's net income.
- Raw Material Costs: Monitor future quarters for the impact of inflation on the cost of sales, given the company's explicit mention of rising raw material costs.
- Debt Covenants: Confirm that the increased line of credit usage ($2.7M) remains within borrowing base limits and does not trigger restrictive covenants.